Comparison of the Efficiency of Bipolar Energy Versus Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia

Sponsor
Brugmann University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02642926
Collaborator
(none)
98
1
2
44
2.2

Study Details

Study Description

Brief Summary

Since the development a few years ago of bipolar energy in the surgery by operative hysteroscopy, the hysteroscopic treatment of menorrhagia by endometrial ablation can be achieved either by the use of monopolar or bipolar current, in parallel with other techniques labelled as 'second generation' (microwave, radio frequency, thermal destruction ...) treating the uterine cavity.

It seems that the use of the bipolar energy decreases the rate of adhesions but prospective data on the success rate after bipolar endometrial ablation are poor and there is currently no recommendation as to the choice of technique to use. No prospective assessment exists to date in the literature to compare the difference in efficacy on bleedings when using monopolar or bipolar current. The goal of this study is to compare these two energies, by measuring the amount of bleeding calculated by the Higham score 12 months after the intervention.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Monopolar current
  • Procedure: Bipolar current
N/A

Detailed Description

Menorrhagia are one of the main symptoms that are managed in Gynecology. The evaluation of the volume of menorrhagia is performed by a PBAC score (pictorial bleeding assesment chart). The one described by Higham allows to quantify and qualify periods as being hemorrhagic when the score is above 150.The surgical treatment of choice has long been hysterectomy.

Many studies evaluating the efficacy, safety and cost of different techniques were performed. A recent review of the literature identified eight randomized clinical trials that showed a slight advantage to the hysterectomy, in comparison with the ablation of the endometrium, for the improvement of symptoms and the patient's satisfaction. Hysterectomy is however associated with a longer surgery duration and a longer recovery period. Moreover, most adverse events (major and minor), were significantly more common after hysterectomy.

A retrospective study examined the long-term results of hysteroscopic endometrectomies. During the monitoring, carried out over 4 to 10 years, menorrhagia stopped in 83.4% of cases. Over the same period, 16.6% of the patients had to undergo hysterectomy because menorrhagia had returned.

In terms of cost, one study showed that the total direct and indirect cost of an hysteroscopic treatment of menorrhagia was significantly lower than that of hysterectomies.Endometrial ablation thus offers an alternative to hysterectomy as surgical treatment of menorrhagia.

Several instances and authors recommend this surgery as first line when medical treatment has failed.Initially, the hysteroscopic surgical treatment of menorrhagia was performed by monopolar endoscopic ablation, which requires the use of glycine as a distension medium. Complications proper to the monopolar ablation were described. Because of these complications, the use of bipolar energy has been developped since several years.

Other techniques known 2nd generation techniques have emerged: use of microwave, radio frequency, thermal destruction of the endometrium. They are all comparable in efficiency with a success rate of around 70% with the disadvantage of not having a comprehensive histology and be much more expensive. This diminishes their use because of the cost of purchase of the device.

Although hysteroscopic bipolar ablation is now a routine technique, there are until now no studies in the literature comparing the efficacy of treatment when using monopolar or bipolar energy, for the endometrial resection by hysteroscopy, for menorrhagia management.The goal of this study is to compare these two energies, by measuring the amount of bleeding calculated by the Higham score 12 months after the intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
98 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Randomized Controlled Trial Comparing the Efficiency of the Bipolar Energy Compared With the Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia
Study Start Date :
Dec 1, 2012
Actual Primary Completion Date :
Aug 1, 2016
Actual Study Completion Date :
Aug 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Monopolar endoscopic endometrial ablation

Procedure: Monopolar current
Hysteroscopic surgical treatment of menorrhagia by use of monopolar current

Experimental: Bipolar endoscopic endometrial ablation

Procedure: Bipolar current
Hysteroscopic surgical treatment of menorrhagia by use of bipolar current

Outcome Measures

Primary Outcome Measures

  1. Bleeding abundance [12 months after surgical intervention]

    Bleeding abundance will be measured by the Higham score, on a questionnaire sent to the patient.

Secondary Outcome Measures

  1. Bleeding abundance [6 months after surgical intervention]

    Bleeding abundance will be measured by the Higham score, on a questionnaire sent to the patient.

  2. Surgery duration [From the entry till the removal of the hysteroscope from the body -ambulatory surgery (max one day)]

    Surgery duration time, measured in minutes. The surgery will be performed according to the standard of care of the hospital, in ambulatory mode.

  3. Per-operative complications rate [From the entry till the removal of the hysteroscope from the body - ambulatory surgery (max one day)]

    Number of complications that occured during the surgery duration. The surgery will be performed according to the standard of care of the hospital, in ambulatory mode.

  4. Post-operative complications rate [6 weeks after the surgical intervention]

    Number of complications that occured after the surgery

  5. Re-do surgery rate [12 months after the surgical intervention]

    Re-do surgery rate, because of hysteroscopic treatment failure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients suffering from menorrhagia

  • Higham score > 150

  • No further pregnancy wish

  • Failure of a former medical treatment

  • Patients consulting a surgeon, for a standard of care surgical intervention

Exclusion Criteria:
  • Pregnant women

  • Menopausal women

  • Patient under anticoagulant treatment, type anti-vitamin K (AVK)

  • Patient with a malign endometrial pathology

  • Patient with one or several known endo-uterine synechia

  • Uterine malformation

  • Active and uncured infection

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Bicêtre, Kremlin Bicêtre (A.P.H.P) Bicêtre France 94270

Sponsors and Collaborators

  • Brugmann University Hospital

Investigators

  • Principal Investigator: André Nazac, MD, CHU Brugmann

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Andre Nazac, Head of clinic, Brugmann University Hospital
ClinicalTrials.gov Identifier:
NCT02642926
Other Study ID Numbers:
  • CHUB-Monobimen
First Posted:
Dec 30, 2015
Last Update Posted:
Aug 8, 2016
Last Verified:
Aug 1, 2016
Keywords provided by Andre Nazac, Head of clinic, Brugmann University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2016